[Myocardial perfusion at rest and during stress. MR signal characteristics of persistent and reversible myocardial ischemia]

Radiologe. 2000 Feb;40(2):155-61. doi: 10.1007/s001170050025.
[Article in German]

Abstract

Aim: Performance of combined rest/stress MR perfusion studies and the analysis of qualitative signal intensity parameters in comparison with 99mTc-SestaMIBI SPECT in patients with known coronary artery disease (CAD).

Methods: Sixteen patients with CAD underwent MR myocardial perfusion assessment at rest and after dipyridamole-induced hyperemia. Qualitative parameters (SI increase, SI upslope) of the SI time-curves were evaluated and characteristics of normal, reversible and persistent hypoperfused myocardium as assessed by 99mTc-SestaMIBI SPECT were compared.

Results: Compared with the rest values, normal myocardium showed a significant increase of the SI upslope during hyperemia (P < 0.001), whereas persistent (P = 0.07) and reversible (P = 0.15) hypo-perfusions showed only minor changes. SI increase over baseline also showed a significant increase only in normal myocardium (P < 0.001). At rest, reversible ischemic areas showed no significant differences from normal myocardium, whereas during hyperemia SI increase was significantly lower (P = 0.02).

Conclusions: Qualitative SI parameters of a combined rest/stress MR myocardial perfusion study allow to differentiate normal from reversibly or persistently hypoperfused myocardium.

Publication types

  • Clinical Trial
  • Comparative Study
  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Contrast Media
  • Coronary Circulation / drug effects
  • Coronary Circulation / physiology*
  • Coronary Disease / diagnosis*
  • Coronary Disease / physiopathology
  • Dipyridamole*
  • Female
  • Gadolinium DTPA
  • Humans
  • Image Processing, Computer-Assisted
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Technetium Tc 99m Sestamibi
  • Tomography, Emission-Computed, Single-Photon
  • Vasodilator Agents*

Substances

  • Contrast Media
  • Vasodilator Agents
  • Dipyridamole
  • Technetium Tc 99m Sestamibi
  • Gadolinium DTPA